Risk stratification of gastrointestinal stromal tumors (GISTs) is based on experience with tumors of the stomach, small bowel, and rectum, which are far more common than GISTs of other sites. In this study from 47 institutions, we analyzed GISTs of the esophagus (n = 102), colon (n = 136), and appendix (n = 27) for their size, mitotic rate, morphology, and outcome to determine which criteria predict their behavior. Esophageal GISTs were small (median: 2.5 cm) with spindle cell morphology and a low mitotic rate (mean: 3.6/5 mm2). Twelve (12%) tumors progressed, including 11 with a mitotic rate >5/5 mm2 and one large (6.8 cm) GIST with a mitotic rate of 2/5 mm2. Colonic GISTs were smaller (median: 1.4 cm) and presented with abdominal pain or bleeding in 29% of cases. Most (92%) were composed of spindle cells with a mean mitotic rate of 4.6/5 mm2. Sixteen (12%) tumors progressed: 14 had mitotic rates >5/5 mm2, and two were >5.0 cm with a mitotic rate <5/5 mm2. All but one appendiceal GIST measured <2.0 cm. These tumors were composed of spindle cells with low mitotic rates (<5/5 mm2), and none progressed. Our results suggest that progression risk among esophageal and colonic GISTs is associated with increased mitotic activity (>5/5 mm2) and size >5.0 cm. These findings support the use of size and mitotic rate for prognostication of GISTs in these locations, similar to tumors of the stomach, small bowel, and rectum.
This is a preview of subscription content
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Kindblom, L. G., Remotti, H. E., Aldenborg, F. & Meis-Kindblom, J. M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 152, 1259–1269 (1998).
Patel, N. & Benipal, B. Incidence of gastrointestinal stromal tumors in the united states from 2001 to 2015: a United States cancer statistics analysis of 50 states. Cureus 11, e4120 (2019).
Kukar, M. et al. Gastrointestinal stromal tumors (GISTs) at uncommon locations: a large population based analysis. J. Surg. Oncol. 111, 696–701 (2015).
Fletcher, C. D. M. et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum. Pathol. 33, 459–465 (2002).
Miettinen, M., El-Rifai, W., Sobin, L. & Lasota, J. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors. Hum. Pathol. 33, 478–483 (2002).
Miettinen, M. & Lasota, J. Gastrointestinal stromal tumors: Pathology and prognosis at different sites. Semin. Diagn. Pathol. 23, 70–83 (2006).
Joensuu, H. et al. Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 13, 265–274 (2012).
Joensuu, H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum. Pathol. 39, 1411–1419 (2008).
Gold, J. S. et al. Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis. Lancet Oncol. 10, 1045–1052 (2009).
Laurini, J. A. et al. Protocol for the examination of resection specimens from patients with gastrointestinal stromal tumor (GIST). GIST Resection 18.104.22.168 2019. https://documents.cap.org/protocols/cp-other-gist-resection-19-4100.pdf.
Robb, W. B. et al. Esophageal gastrointestinal stromal tumor: Is tumoral enucleation a viable therapeutic option? Ann. Surg. 261, 117–124 (2015).
Schizas, D. et al. Prognostic factors affecting mortality in patients with esophageal GISTs. J. BUON. 25, 497–507 (2020).
Pence, K. et al. Management of esophageal gastrointestinal stromal tumor: review of one hundred seven patients. Dis. Esophagus 30, 1–5 (2017).
Lott, S. et al. Gastrointestinal stromal tumors of the esophagus: evaluation of a pooled case series regarding clinicopathological features and clinical outcome. Am. J. Cancer Res. 5, 333–343 (2014).
Radenkovic, G. et al. C-kit-immunopositive interstitial cells of Cajal in human embryonal and fetal oesophagus. Cell Tissue Res. 340, 427–436 (2010).
Abraham, S. C., Krasinskas, A. M., Hofstetter, W. L., Swisher, S. G. & Wu, T. T. “Seedling” mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am. J. Surg. Pathol. 31, 1629–1635 (2007).
Miettinen, M., Sarlomo-Rikala, M., Sobin, L. H. & Lasota, J. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am. J. Surg. Pathol. 24, 1339–1352 (2000).
Feng, F. et al. Clinicopathological features and prognosis of colonic gastrointestinal stromal tumors: evaluation of a pooled case series. Oncotarget 7, 40735–40745 (2016).
Liu, Z. et al. Colonic gastrointestinal stromal tumor: a population-based analysis of incidence and survival. Gastroenterol. Res. Pract. 2019, 3849850 (2019).
Kaneko, M. et al. Giant gastrointestinal stromal tumor of the vermiform appendix: a case report. Mol. Clin. Oncol. 7, 399–403 (2017).
Mourra, N., Matalka, I. & Arrive, L. Incidental finding of gastrointestinal stromal tumor in the appendix. Appl. Immunohistochem. Mol. Morphol. 28, e31–e32 (2020).
Thomsen, T., Ernst, M. & Gottschalk, U. Gastrointestinal stromal tumor of the appendix, extremely rare, mostly benign. Ultraschall. Med. 37, PS6_05 (2016).
Vassos, N. et al. A novel complex KIT mutation in a gastrointestinal stromal tumor of the vermiform appendix. Hum. Pathol. 44, 651–655 (2013).
Lee, M. H., Lee, H. K., Yi, B. H. & Kim, H. K. Gastrointestinal stromal tumor of the appendix mimicking a mucinous cystadenocarcinoma: a case report. J Korean Soc. Radio. 65, 81–83 (2011).
Chung, J. C. & Song, O. P. Gastrointestinal stromal tumor of the appendix. Turk. J. Gastroenterol. 23, 303–304 (2012).
Elazary, R. et al. Malignant appendiceal GIST: case report and review of the literature. J. Gastrointest. Cancer 41, 9–12 (2010).
Miettinen, M. et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum. Am. J. Surg. Pathol. 27, 625–641 (2003).
Miettinen, M. et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases. Am. J. Surg. Pathol. 25, 1121–1133 (2001).
Miettinen, M., Sobin, L. H. & Lasota, J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am. J. Surg. Pathol. 29, 52–68 (2005).
Miettinen, M., Makhlouf, H., Sobin, L. H. & Lasota, J. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am. J. Surg. Pathol. 30, 477–489 (2006).
Emory, T. S., Sobin, L. H., Lukes, L., Lee, D. H. & O’Leary, T. J. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am. J. Surg. Pathol. 23, 82–87 (1999).
Miettinen, M. & Lasota, J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch. Pathol. Lab. Med. 130, 1466–1478 (2006).
Agaimy, A. Gastrointestinal stromal tumors (GIST) from risk stratification systems to the new TNM proposal: more questions than answers? A review emphasizing the need for a standardized GIST reporting. Int. J. Clin. Exp. Pathol. 3, 461–471 (2010).
We thank Dr. William Jeck of Duke University for his contribution to this study. The author(s) received no specific funding for this work.
The authors declare no competing interests.
The components of the study conducted at each institution were approved by their respective institutional review boards.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Hu, S., Alpert, L., Cates, J.M.M. et al. Gastrointestinal stromal tumors (GISTs) arising in uncommon locations: clinicopathologic features and risk assessment of esophageal, colonic, and appendiceal GISTs. Mod Pathol (2021). https://doi.org/10.1038/s41379-021-00949-w